Autonomix Medical regains Nasdaq compliance on minimum bid price rule

Autonomix Medical, Inc.

Received Nasdaq deficiency letter on Jan 14, 2026 for bid price below $1.00 per share.
On July 9, 2026, notified of regained compliance after 10 consecutive business days (June 24-July 8) with closing bid price at or above $1.00.
The matter is closed; no immediate delisting risk from Nasdaq Capital Market.

Featured in Daily 8-K Digest

Selected #2 for 2026-07-10. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.